Skip to main content
. 2013 Sep 25;11:228. doi: 10.1186/1479-5876-11-228

Figure 1.

Figure 1

fERG modulation function in patients carriers of the CFH (rs1061170) polymorphism. Mean fERG amplitudes (± SE) as a function of modulation depth, at baseline (V0) and after three (V3), six (V6), nine (V9) and twelve (V12) months of Saffron treatment, are represented separately for wild type (n = 6), heterozygous (n = 20) and homozygous (n = 7) patients for the CFH (rs1061170) polymorphism.